Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Investigating multi-dimensional problems in drug substance

"Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise."

Our CSO, Gareth Jenkins, and Head of Drug Substance, Paul Quigley, have shared their insights into the importance of investigations during drug substance development. This article in the Chemistry Detectives issue of Chemistry World explores how solutions are found to enhance scalability, efficiency and economy. It provides details on how metabolic and pharmacokinetic studies are used to determine drug compound fate and how our solid-state team investigates physical forms. You can also learn about our use of synthetic biology to accelerate process development.

You can read the full article here on the Chemistry World website




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH